Our experience suggested that local treatment of ABS can be a potentially successful therapy for the management of intractable or incurable chronic ulcers in patients with BD or for other ischemic or vasculitic skin problems.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Ankaferd hemostat (Ankaferd Blood Stopper; ABS) is a pro-hemostatic agent affecting erythrocytes.
📊
Temel Bulgular & Veri:In this article, we report a 50-year-old male patient who presented with a non-healing leg ulcer for one year.
💡
Sonuç & Katkı:Our experience suggested that local treatment of ABS can be a potentially successful therapy for the management of intractable or incurable chronic ulcers in patients with BD or for other ischemic or vasculitic skin problems.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Ankaferd hemostat (Ankaferd Blood Stopper; ABS) is a pro-hemostatic agent affecting erythrocytes. In this article, we report a 50-year-old male patient who presented with a non-healing leg ulcer for one year. He had a past medical history of Behçet’s disease (BD) diagnosed at the age of 29 and therapy was started. Patient's leg ulcer did not respond to any treatment. Topical ABS was applied to the patient's leg ulcer daily. Our experience suggested that local treatment of ABS can be a potentially successful therapy for the management of intractable or incurable chronic ulcers in patients with BD or for other ischemic or vasculitic skin problems.
🔖
Bu Makaleye Atıf Yap
ÇİFTÇİLER, R., ÇİFTÇİLER, E., HAZNEDAROĞLU, İ. C. (2019). Effective Ankaferd Hemostat Treatment For Severe Intractable Chronic Deep Leg Ulcer Associated With Behçet’s Disease. art, Cilt: 34 - Sayı: 4, 457–460. https://ajindex.com/articles/148272
Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 2010;15:329-36
Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008;36:163-70
Koçak E, Akbal E, Ta A, Köklü S, Karaca G, Can M, et al. Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model. Saudi J Gastroenterol 2013;19:126-30
Saribas Z, Sener B, Haznedaroglu IC, Hascelik G, Kirazli S, Goker H. Antimicrobial activity of ankaferd blood stopper® against nosocomial bacterial pathogens. Cent. Eur J Med 2010;5:198-202
Ciftci S, Keskin F, Keceli Ozcan S, Erdem MA, Cankaya B, Bingol R, et al. In Vitro Antifungal Activity of Ankaferd Blood Stopper Against Candida albicans. Curr Ther Res Clin Exp 2011;72:120-6
Kuru S, Kismet K, Bag YM, Barlas AM, Senes M, Durak M, et al. Does the application of Ankaferd Blood Stopper rectally have positive effects on the healing of colorectal anastomosis and prevention of anastomotic leakage? An experimental study. Biomed Pharmacother 2017;96:968-73
Hasgul R, Uysal S, Haltas H, Akyol S, Yuksel Y, Gurel A, et al. Protective effects of Ankaferd blood stopper on aspirin-induced oxidative mucosal damage in a rat model of gastric injury. Toxicol Ind Health 2014;30:888-95
Jung JY, Kim DY, Bang D. Leg ulcers in Behçet’s disease. Br J Dermatol 2008;158:178-9
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28:338-47
Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med 1999;341:1284-91
Lee ES, Bang D, Lee S. Dermatologic manifestation of Behçet’s disease. In: Lee S, Bang D, Lee ES, Sohn S, editors. Behçet’s Disease A Guide to its Clinical Understanding. Berlin Heidelberg: Springer; 2001. p. 129-36
Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidencebased recommendations for the management of Behçet disease. Ann Rheum Dis 2009;68:1528-34.